GlobeNewswire Inc.··Tiziana Life SciencesTiziana's Long COVID Treatment Shows Promise in Peer-Reviewed Study
Tiziana Life Sciences reports positive preclinical data for intranasal foralumab in treating Long COVID neuroinflammation and cognitive dysfunction.
TLSAALSAlzheimer's disease